Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy

CompletedOBSERVATIONAL
Enrollment

420

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2015

Conditions
Non-hematologic Cancer
Trial Locations (20)

10003

Hospital San Pedro de Alcántara, Cáceres

11407

Hospital de Jerez, Jerez de la Frontera

15006

Hospital Teresa Herrera, A Coruña

17007

Hospital Dr. Josep Trueta, Girona

18014

Hospital Virgen de las Nieves, Granada

20080

Hospital de Donosti, San Sebastián

27004

Hospital de Lugo, Lugo

30008

Hospital Morales Meseger, Murcia

31008

Hospital de Navarra, Pamplona

32005

Complejo Hospitalario de Ourense, Ourense

36204

Hospital Xeral, Vigo

43003

Hospital de Santa Tecla, Tarragona

45004

Hospital Virgen de la Salud, Toledo

46015

Hospital Arnau de Vilanova, Valencia

46017

Hospital Universitario Doctor Peset, Valencia

47005

Hospital Clínico de Valladolid, Valladolid

48013

Hospital de Basurto, Basurto

02006

Hospital Universitario Albacete, Albacete

03010

Hospital Clínico Universitario San Juan de Alicante, Alicante

08023

Hospital Quirón, Barcelona

All Listed Sponsors
lead

Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología

OTHER

NCT01799421 - Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy | Biotech Hunter | Biotech Hunter